E-LIB Suche - Ergebnisse für: Delforge, M.L.

1

PCR127 Needs and Experiences of Patients and Healthcare Pro..:

Schoefs, E. ; Verbeke, C. ; Broekmans, J....
Value in Health. 26 (2023) 12 - p. S473 , 2023

Link: https://doi.org/10.1016/..

2

B08 IDECABTAGENE VICLEUCEL VERSUS STANDARD REGIMENS IN PATI..:

Rodríguez-Otero, P. ; Ailawadhi, S. ; Arnulf, B....
HemaSphere. 7 (2023) S2 - p. 7-8 , 2023

Link: https://doi.org/10.1097/..

3

CO93 Matching-Adjusted Indirect Treatment Comparison (MAIC)..:

Moreau, P. ; Usmani, S.Z. ; van de Donk, N.W.C.J....
Value in Health. 26 (2023) 12 - p. S31 , 2023

Link: https://doi.org/10.1016/..

4

P16 HEALTH-RELATED QUALITY OF LIFE FOR FRAIL TRANSPLANT-INE..:

Facon, T. ; Plesner, T. ; Usmani, S....
HemaSphere. 7 (2023) S2 - p. 18-19 , 2023

Link: https://doi.org/10.1097/..

5

P20 Matching-Adjusted Indirect Treatment Comparison (MAIC) ..:

Moreau, P. ; Usmani, S.Z. ; van de Donk, N.W.C.J....
Value in Health. 26 (2023) 12 - p. S5-S6 , 2023

Link: https://doi.org/10.1016/..

6

P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-..:

Popat, R. ; Moreau, P. ; Usmani, S. Z....
HemaSphere. 6 (2022) - p. 812-813 , 2022

Link: https://doi.org/10.1097/..

7

P960: HEALTH-RELATED QUALITY OF LIFE IN THE LOCOMMOTION STU..:

Delforge, M. ; Moreau, P. ; Einsele, H....
HemaSphere. 6 (2022) - p. 850-851 , 2022

Link: https://doi.org/10.1097/..

8

P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN I..:

Delforge, M. ; Usmani, S. Z. ; van de Donk, N. W....
HemaSphere. 6 (2022) - p. 789-790 , 2022

Link: https://doi.org/10.1097/..

9

B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CH..:

van de Donk, NWCJ ; Delforge, M ; Agha, M...
HemaSphere. 6 (2022) - p. 9-10 , 2022

Link: https://doi.org/10.1097/..

10

P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TE..:

Einsele, H. ; Moreau, P. ; Delforge, M....
HemaSphere. 6 (2022) - p. 825-826 , 2022

Link: https://doi.org/10.1097/..

11

P12: TREATMENTS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIP..:

Vekemans, M-C ; Delforge, M ; Anguille, S...
HemaSphere. 6 (2022) - p. 17-18 , 2022

Link: https://doi.org/10.1097/..

12

PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS ..:

Rosinol, L. ; Usmani, S. Z. ; Bahlis, N....
HemaSphere. 6 (2022) - p. 1885-1886 , 2022

Link: https://doi.org/10.1097/..

13

P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING..:

Avivi, I. ; H vesole, D. ; Dávila Valls, J....
HemaSphere. 6 (2022) - p. 782-783 , 2022

Link: https://doi.org/10.1097/..

14

P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY ..:

Hillengass, J. ; Cohen, A. D. ; Delforge, M....
HemaSphere. 6 (2022) - p. 849-850 , 2022

Link: https://doi.org/10.1097/..

15

P53 Patient Preferences for Multiple Myeloma Treatment: A S..:

Janssens, R. ; Lang, T. ; Vallejo, A....
Value in Health. 25 (2022) 7 - p. S298 , 2022

Link: https://doi.org/10.1016/..